The Centre hospitalier universitaire de Sherbrooke is the public healthcare network in Sherbrooke, Quebec, Canada, affiliated with the Université de Sherbrooke Faculty of Medecine.

There are 690 beds in Centre hospitalier de l'Université de Sherbrooke.

During the past decade, Centre hospitalier de l'Université de Sherbrooke conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre hospitalier de l'Université de Sherbrooke" #1 sponsor was "Université de Sherbrooke" with 4 trials, followed by "Unity Health Toronto" with 2 trials sponsored, "Cell Genesys" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Montreal Heart Institute" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre hospitalier de l'Université de Sherbrooke" #1 collaborator was "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Fonds de la Recherche en Santé du Québec" with 1 trials as a collaborator and "Foundation of the Stars" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Centre hospitalier de l'Université de Sherbrooke" are "Community-acquired Pneumonia, Influenza, COVID-19" (1 trials), "Critical Illness" (1 trials), "Critically Ill" (1 trials), "Direct Extubation" (1 trials) and "Infective Endocarditis" (1 trials). Many other conditions were trialed in "Centre hospitalier de l'Université de Sherbrooke" in a lesser frequency.

Most popular intervention types in "Centre hospitalier de l'Université de Sherbrooke" are "Drug" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials), "Angiotensin Receptor Blockers" (1 trials) and "Angiotensin converting enzyme inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre hospitalier de l'Université de Sherbrooke" are 5 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centre hospitalier de l'Université de Sherbrooke". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centre hospitalier de l'Université de Sherbrooke, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre hospitalier de l'Université de Sherbrooke, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".